BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
Copyright: ©Author(s) 2026.
World J Crit Care Med. Jun 9, 2026; 15(2): 118885
Published online Jun 9, 2026. doi: 10.5492/wjccm.v15.i2.118885
Table 1 Inclusion and exclusion criteria
Inclusion
Exclusion
Published in EnglishAll languages other than English
Data collected on or after March 1, 2023Data collected before March 1, 2023
All or part of the analyses targeted FL HCWs caring for patients with COVID-19: Physicians, nurses, advanced practice providersReports limited to the context of another pandemic (e.g., Middle East Respiratory Syndrome, influenza) or event (e.g., earthquake or another natural event) not related to the COVID-19 pandemic
Reporting quantitative data (e.g., prevalence rates) on psychological problems experienced by FL HCWs after the COVID-19 pandemicReports limited to other professionals not working in the health system (i.e., police officers, firefighters, teachers) or healthcare students
Reporting quantitative data (e.g., prevalence rates) on psychological problems (i.e., depressive symptoms, anxiety symptoms, insomnia, posttraumatic stress disorder symptoms) and other psychological data, including burnout symptoms, sleep problems, psychological stress and distress)Reports limited to HCWs who did not perform hospital-based work as a member of the primary healthcare team on hospitalized COVID-19 patients (i.e., dentists, orthopedic surgeons)
Reports limited to types of qualitative data other than prevalence rates or results of interventional studies
Reports limited to data on emotions (e.g., fear) or behaviors (e.g., physical activity, smoking)
Reports limited to surges of COVID-19 infection occurring locally at time of study (i.e., several provinces in China had surges in early 2023; studies reporting data collection during these surges were excluded)
Table 2 Study characteristics, n (%)/mean ± SD
Ref.
Country
Survey year
Occupation
Comparison
Number of participants
Age (mean ± SD or most common age group)
Men
Depression screen
Anxiety screen
PTSD screen
Sleep screen
Distress screen
Azoulay et al[10]Europe2024ICU HCWsNone85039 ± 7276 (32)YesYesNoNoYes
Cheng et al[11]Taiwan2023Nurse practitionersNone9835-443 (3.1)YesYesNoNoYes
Yang et al[12]China2023NursesNone2,06526-35370 (17.9)YesYesNoYesNo
Qian et al[13]China2023HCWsFL vs NFL141926-35343 (24.2)NoNoNoNoYes
Mohr et al[14]United States2018-2023HCWsYear; FL vs NFL29316446.3 ± 12.183258 (28.4)NoNoNoNoYes
Liu et al[15]China2023HCWsNone207025-34469 (22.7)YesYesYesYesNo
Wen et al[16]China2022, 2023Nurses, physiciansYear; ICU229231-40389 (17.0)NoNoYesNoNo
Narita et al[17]Japan2023HCWsFL vs NFL66042.7 ± 10.9214 (32.4)NoNoYesNoNo
Liu et al[18]China2023NursesYear784NR366 (49.6)YesYesNoYesNo
Giménez-Díez et al[19]Spain2023NursesYear; FL vs NFL104542.7 ± 10.9128 (12.2)YesYesYesYesNo
Xu et al[20]China2023Nurses, physiciansNone2094< 35 517 (24.7)YesYesNoNoYes
Xie et al[21]China2023NursesFL vs NFL25318-4522 (8.7)YesYesNoYesNo
Wang et al, 2023[22]China2023NursesNone221026-35 436 (19.7)YesYesNoNoNo
Zhang et al[23]China2023NursesFL vs NFL251325-4498 (3.9)NoNoYesNoYes
Wang et al, 2024[24]China2023NursesNone221026-35436 (19.7)NoNoNoNoYes
Ding et al[25]China2023HCWsFL vs NFL141218-34609 (43.1)YesYesNoYesNo
Yang et al[26]China2022, 2023NursesYear816NR381 (49.9)YesYesNoYesNo
Çerçizaj et al[27]Albania2024NursesFL vs NFL28838.6 ± 10.452 (17.9)YesYesNoNoYes
Hoseini-Marvast et al[28]Iran2023NursesFL vs NFL89034.89 ± 7.84107 (12.0)YesYesNoNoNo
Table 3 Depression data, n (%)/mean ± SD
Ref.
Depression screening tool
Positive depression screen definition
Depression prevalence
Depression survey score
Results of comparison
Azoulay et al[10]HADS7 of 21 on the depression subscale219 (26)Mean NR; median 4 (IQR: 2-7)NCG
Cheng et al[11]DASS-21> 9NR8.2 ± 6.9NCG
Yang et al[12]SDS ≥ 40NR53.6 ± 13.1NCG
Hoseini-Marvast et al[28]Beck-2Minimal 0-7, mild 8-15, moderate 16-25, severe 26-63845 (50)20.8 ± 13.7Not significant for comparison between FL vs NFL (data NR)
Çerçizaj et al[27]DASS-21Mild 10-13, moderate 14-20, severe 21-27, extremely severe ≥ 28Mild 16 (5.6); moderate 11 (3.8); severe/extremely severe 9 (3.1)NROR 2.67 (95%CI: 1.2-6.1) for FL vs NFL
Liu et al[15]PHQ-9≥ 5865 (41.8) (95%CI: 39.7-43.9)NRNCG
Yang et al[26]SDS≥ 40NR55.4 ± 12.8Mean 62.46 ± 4.69 in 2022 vs 55.4 ± 12.8 in 2023, P < 0.001
Ding et al[25]PHQ-9≥ 10231 (16.4)NROR 1.66 (95%CI: 1.47-1.9) P < 0.001 for FL vs NFL
Liu et al[18]SDS≥ 73 for severe depression36 (4.9)55.6 ± 12.6Prevalence 36 (4.9) in 2023 vs 13 (1.7) in 2022, P < 0.001
Giménez-Díez et al[19]PHQ-9Pooled symptom profile191 (73.9)8.9 ± 5.9OR = 1.38 (95%CI: 1.00-1.90), P = 0.048 FL vs NFL
Xu et al[20]CES-DPooled symptom profile1300 (62.1) low, 605 (28.9) moderate and 189 (9) highNRNCG
Xie et al[21]SDS≥ 50137 (64.9)NROR = 1.44 (95%CI: 0.39-1.25), P = 0.017 FL vs NFL
Wang et al[22]SDS≥ 50NR54.3 ± 9.4NCG
Table 4 Anxiety data, n (%)/mean ± SD
Ref.
Anxiety screening tool
Positive anxiety screen cutoff
Estimated anxiety prevalence
Anxiety survey score
Results of comparison
Azoulay et al[10]HADS≥ 7492 (58)median score 7 (IQR 5-10)NCG
Cheng et al[11]DASS-21> 7NR6.92 ± 6.32NCG
Yang et al[12]SAS ≥ 50NR49.62 ± 11.9NCG
Liu et al[12]GAD-7≥ 5638 (30.8) (95%CI: 28.8-32.8)NRNCG
Liu et al[18]SASNRNR51.5 ± 12.2Mean SAS 69.6 ± 5.04 in 2022 vs in 51.5 ± 12.2 in 2023, P < 0.001
Giménez-Díez et al[19]GAD-7Dichotomous MH variable (no/mild vs moderate/severe); GAD-7 cutoff not provided839 (80.3)9.4 ± 5.7OR for FL vs NFL 1.38 (95%CI: 1.00-1.90)
Xu et al[20]GAD-7Psychological symptom profile created: Low, moderate, and high level1300 (62.1) low, 605 (28.9) moderate, and 189 (9) highNRNCG
Xie et al[21]GAD-7≥ 5120 (56.9)NROR = 0.67 (95%CI: 0.36-1.24), P = 0.20
Wang et al[22], 2023SAS≥ 361438 (65.1)NRNCG
Ding et al[25]GAD-7≥ 10254 (18)NROR for FL vs NFL 2.047 (95%CI: 1.68-2.24), P < 0.001
Yang et al[26]SAS≥ 50 61 (8.0)51.4 ± 12.2426 (52.3) in 2022 vs 61 (8.0) in 2023, P < 0.001
Çerçizaj et al[27]DASS-21Normal 0-7, mild 8-9, moderate 10-14, severe 15-19, extremely severe 20+Mild 9 (3.1), moderate 25 (8.7), severe 3 (1), extremely severe 9 (3.1)NROR for FL vs NFL 4.17 (95%CI: 1.6-10.6), P = 0.003
Hoseini-Marvast et al[28]Beck anxiety inventoryLow 0-13, mild 14-19, moderate 20-28, severe 29-63579 (65)22 ± 13.4NS FL vs NFL (data NR)
Table 5 Sleep disorder data, n (%)
Ref.
Sleep screening tool
Positive sleep screen definition
Sleep prevalence in FL 2023
mean ± SD
Results of comparison
Yang et al[12]PSQI ≥ 81088 (52.70)10.11 ± 4.2NCG
Liu et al[15]ISI≥ 8782 (34.3) (95%CI: 32.2-36.3)NRNCG
Liu et al[18]PSQI≥ 8NR9.4 ± 4.710.7 ± 2.5 in 2022 and 9.4 ± 4.7 in 2023, P < 0.001
Giménez-Díez et al[19]ISINR698 (66.80)10.8 ± 6.4NR
Xie et al[21]PSQI≥ 7201 (79.4)NRNR
Ding et al[25]ISI≥ 15289 (20.5)NROR for FL vs NFL 1.09 (95%CI: 1.02-1.16), P = 0.01
Yang et al[26]PSQI≥ 8NR9.3 ± 4.710.7 ± 2.5 in 2022 vs 9.3 ± 4.7 in 2023, P < 0.001
Table 6 Distress and turnover intention table, n (%)/mean ± SD
Ref.
Distress screening tool
Distress screen definition
Distress prevalence in FL 2023
mean ± SD
Results of comparison
Azoulay et al[10]VAS and intention to leave yes/noNRIntention to leave 484 (57); VAS NRNRNCG
Cheng et al[11]DASS-21 and Stress Scale of Caring for Patients with Highly-Infectious Disease> 14NRDASS-21 stress score 1324 ± 8.14; HSS 48.89 ± 18.5NCG
Qian et al[13]IES-R; change in work stress and rest time yes/noNRNRIES-R score 173 ± 12.7NS increase in work stress and decrease in rest time reported in FL vs NFL
Mohr et al[14]2 items from MBI and coronavirus disease 2019 professional stressBurnout ≥ once per week; coronavirus disease 2019 professional stress positive if answered high or extreme stress95278 (32.50)ICU had highest work stress at the start of the pandemic (48.6%) with the greater decline (12.9%) from 2020-2023 than other work areas
Xu et al[20]MBIPsychological symptom profile created: Low, moderate, and high level1300 (62.1) low level, 605 (28.9) moderate level, and 189 (9) high levelNRNCG
Zhang et al[23]Turnover Intention Scale< 6 very low; 6-12 low; 13-18 high; > 19 very highHigh turnover intention 804 (32) and very high 302 (12)NRFL 2.09 ± 0.88 vs NFL 1.85 ± 1.85, P < 0.01
Wang et al[24]MBI-HSS> 26 in EE, > 9 in D, and < 33 in PA1666 (75.38)NRNCG
Çerçizaj et al[27]DASS-21Normal 0-14, mild 15-18, moderate 19-25, severe 26-33, extremely severe ≥ 34Mild 3 (1.0), Moderate 0 (0), severe or extremely severe 0 (0)NRNR


Write to the Help Desk